Abbott Laboratories Resets Portfolio With Exact Sciences Cancer Diagnostics Deal [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott Laboratories, NYSE:ABT, is repositioning its business after ongoing challenges in its Nutrition segment. The company is advancing a major acquisition of Exact Sciences to expand into oncology diagnostics. Management is also increasing focus on diabetes and cardiovascular products as part of a broader transformation. Abbott Laboratories, NYSE:ABT, is in the middle of a significant reset as it contends with persistent pressure in its Nutrition business. The stock closed at $109.3, with a 1.8% gain over the past week, but returns over the past month, year, and five years show declines of 12.8%, 13.0%, and 3.4% respectively. That mixed picture helps explain why the company is making bigger moves rather than relying on incremental tweaks. The planned acquisition of Exact Sciences puts cancer diagnostics at the center of Abbott's next phase, alongside a sharper push into diabetes and cardiovascular products. For investors, the key questions now are how well Abbott integrates
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillationPR Newswire
- ?????????????????????????????????????2035????38???????????????????????????(CAGR)?6.11%?????????? [CNET News]CNET News
- Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths [CNET News]CNET News
- Do Wall Street Analysts Like Abbott Laboratories Stock? [Yahoo! Finance]Yahoo! Finance
- AbbVie's (NYSE:ABBV) Q4 CY2025: Beats On Revenue [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 2/6/26 - Form 4
- 1/26/26 - Form 4
- 1/22/26 - Form 8-K
- ABT's page on the SEC website